In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem

CS-834 is a prodrug of the carbapenem R-95867, developed by Sankyo Co., Ltd., Tokyo, Japan. To investigate the possibility that CS-834 may be the first carbapenem usable in an oral dosage form, its in vitro antibacterial activity (as R-95867) and in vivo antibacterial activity were compared with tho...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Yamaguchi, Keizo, Domon, Haruki, Miyazaki, Shuichi, Tateda, Kazuhiro, Ohno, Akira, Ishii, Kazuhiro, Matsumoto, Tetsuya, Furuya, Nobuhiko
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105498/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9517932/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.3.555
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!